Medicines labeled for the same conditions
Alternatives to trandolapril
71 other medicines are given the same way (oral) and in the same FDA class as trandolapril or labeled mainly for the same use (high blood pressure); 15 are in its class, angiotensin converting enzyme inhibitors: lisinopril, enalapril, hydrochlorothiazide and lisinopril, amlodipine and benazepril and 11 more; the others include 9 beta-adrenergic blockers, 8 calcium channel blockers and 8 thiazide diuretics (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.0254 per lisinopril 20 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as trandolapril?
The first 24 of the 71, the same class first. High blood pressure lists all 88 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Trandolaprilangiotensin converting enzyme inhibitor | this medicine | 5 labelers | $0.157 per tablet 1 mg tablet | Yes | No current entry |
| Lisinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry |
| Enalaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 29 labelers | $0.0664 per tablet 10 mg tablet | Yes | No current entry |
| Hydrochlorothiazide and lisinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 27 labelers | $0.0293 per tablet 10-12.5 mg tablet | Yes | No current entry |
| Amlodipine and benazeprilcalcium channel blocker · same class | High blood pressure | 16 labelers | $0.114 per unit 10-20 mg | Yes | No current entry |
| Benazeprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 21 labelers | $0.0789 per tablet 20 mg tablet | Yes | No current entry |
| Ramiprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 17 labelers | $0.0707 per capsule 10 mg capsule | Yes | No current entry |
| Captoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 13 labelers | $0.228 per tablet 12.5 mg tablet | Yes | No current entry |
| Quinaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 9 labelers | n/a | Yes | In shortage |
| Benazepril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 3 labelers | $0.222 per tablet 20-12.5 mg tablet | Yes | No current entry |
| Fosinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 7 labelers | $0.154 per tablet 10 mg tablet | Yes | No current entry |
| Hydrochlorothiazide and quinaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 4 labelers | n/a | Yes | In shortage |
| Enalapril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 2 labelers | $0.209 per tablet 10-25 mg tablet | Yes | No current entry |
| Captopril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 1 labeler | n/a | Yes | No current entry |
| Fosinopril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 2 labelers | $0.634 per tablet 10-12.5 mg tablet | Yes | No current entry |
| Perindoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 1 labeler | $0.495 per tablet 4 mg tablet | Yes | No current entry |
| Metoprololbeta-adrenergic blocker | High blood pressure | 64 labelers | $0.085 per tablet 100 mg tablet | No | A presentation being discontinued |
| Diltiazemcalcium channel blocker | High blood pressure | 42 labelers | $0.144 per capsule 24h ER(cd) 120 mg capsule | No | A presentation being discontinued |
| Propranololbeta-adrenergic blocker | High blood pressure | 38 labelers | $0.0493 per tablet 20 mg tablet | No | In shortage |
| Losartanangiotensin 2 receptor blocker | High blood pressure | 44 labelers | $0.0327 per tablet 50 mg tablet | Yes | No current entry |
| Amlodipinecalcium channel blocker | High blood pressure | 42 labelers | $0.0102 per tablet 5 mg tablet | No | No current entry |
| Clonidinecentral alpha-2 adrenergic agonist | High blood pressure | 37 labelers | $0.0241 per tablet 0.1 mg tablet | No | No current entry |
| Valsartanangiotensin 2 receptor blocker | High blood pressure | 34 labelers | $0.0963 per tablet 40 mg tablet | Yes | A presentation being discontinued |
| Nifedipinedihydropyridine calcium channel blocker | High blood pressure | 32 labelers | $0.130 per tablet 30 mg tablet | No | No current entry |
| Atenololbeta-adrenergic blocker | High blood pressure | 35 labelers | $0.0217 per tablet 25 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Trandolapril: the full record
- label, generics, price, shortages, recalls
- Lisinopril vs trandolapril
- two records side by side
- Trandolapril vs ramipril
- two records side by side